Gary A. Fahle
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility 5
- Tuberculosis Research and Epidemiology 4
- Immunology top 5%
- Animal Science and Zoology top 2%
- Oncology top 5%
- Polyomavirus and related diseases 6
- Viral-associated cancers and disorders 4
- Epidemiology top 5%
- Cytomegalovirus and herpesvirus research 7
- Pneumocystis jirovecii pneumonia detection and treatment 4
- Mycobacterium research and diagnosis 3
-
- Virus-based gene therapy research 3
- Co-authors
- Steven H. FischerEugene O. MajorJean HouCaroline F. RyschkewitschLeatrice VogelSherif R. ZakiJosephine M. McAuliffeBrian R. Murphy
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Gary A. Fahle
41 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Infectious Diseases 799
- Immunology 488
- Animal Science and Zoology 213
- Oncology 559
- Epidemiology 659
Countries citing papers authored by Gary A. Fahle
This map shows the geographic impact of Gary A. Fahle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary A. Fahle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary A. Fahle more than expected).
Fields of papers citing papers by Gary A. Fahle
This network shows the impact of papers produced by Gary A. Fahle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary A. Fahle. The network helps show where Gary A. Fahle may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gary A. Fahle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2020 | 118 | |
| 3 | 2019 | 1 | |
| 4 | 2018 | 30 | |
| 5 | 2014 | 14 | |
| 6 | 2014 | 22 | |
| 7 | 2014 | 47 | |
| 8 | 2013 | 79 | |
| 9 | 2012 | 10 | |
| 10 | 2011 | 217 | |
| 11 | Bench to bedside: development and implementation of a clinical protocol for the early molecular detection for the improved diagnosis of invasive pulmonary aspergillosis and zygomycosis | 2009 | 1 |
| 12 | Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathybreakdown → | 2006 | 561 |
| 13 | 2004 | 109 | |
| 14 | 2004 | 310 | |
| 15 | 2004 | 152 | |
| 16 | 2003 | 19 | |
| 17 | Comparison of a quantitative Real-Time PCR assay with pp65 antigenemia and NucliSens pp67 mRNA for detection of cytomegalovirus viremia in bone marrow transplant patients | 2001 | 1 |
| 18 | 2001 | 50 | |
| 19 | 1999 | 6 | |
| 20 | 1996 | 9 |
About Gary A. Fahle
Gary A. Fahle is a scholar working on Microbiology, Infectious Diseases and Epidemiology, having authored 42 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (7 papers), Polyomavirus and related diseases (6 papers), Antifungal resistance and susceptibility (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Viral-associated cancers and disorders (4 papers), Tuberculosis Research and Epidemiology (4 papers), Virus-based gene therapy research (3 papers) and Mycobacterium research and diagnosis (3 papers). The work is most often cited by research in Infectious Diseases (799 citations), Immunology (488 citations) and Animal Science and Zoology (213 citations). Gary A. Fahle has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Steven H. Fischer, Eugene O. Major, Jean Hou, Caroline F. Ryschkewitsch, Leatrice Vogel, Sherif R. Zaki, Josephine M. McAuliffe, Brian R. Murphy, Kanta Subbarao and Ernst‐Wilhelm Radue. Their work appears in journals such as New England Journal of Medicine, Nature Medicine and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.